Depression symptoms of African American patients with cancer under-recognized
the ONA take:
Depression symptoms of African American patients with cancer are often under-recognized, a new study by researchers at Case Western Reserve University in Cleveland, Ohio, has found.
For the study, researchers sought to investigate whether depression in African American patients with cancer goes under-recognized for treatment.
The researchers identified 34 depressed African American cancer patients, 23 non-depressed African American cancer patients, and 17 depressed Caucasian cancer patients at a Northeast Ohio medical center.
All participants had been diagnosed with early-stage breast or prostate cancer within the last 3 years and received their last treatment at least 6 months ago. Patients were asked open-ended questions to assess their depression.
Results showed that depressed African American patients reported more irritability, wanting to be alone, insomnia, fatigue, and crying than non-depressed black patients.
Researchers also found that depressed black patients reported sad feelings less frequently than depressed white patients. Black patients were also more likely to use words like "feeling down," "low," "gloomy," or "blue" to describe their feeling rather than "depressed."
Depression symptoms of African American patients with cancer are often under-recognized.
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Immunotherapy and the Future of Prostate Cancer Treatment
- Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments
- Patients With Urologic Cancer Need Psycho-oncologic Support to Manage High Stress
- E-cigarettes and Replacement Nicotine Therapy Safer Than Tobacco Use
- Lung Cancer Screening Rates Low Among Present and Former Smokers
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Patients Undergoing Multiple Systemic Therapies for Metastatic Prostate Cancer Expect a Cure
- FDA Grants Priority Review to Ceritinib for First-line Treatment of ALK+ NSCLC
- Overall Health Worse in African American Men Undergoing Active Surveillance For Prostate Cancer
- Clinical Benefit of Simtuzumab Inconsistent for Myelofibrosis
- Follow-up Rates in Active Surveillance for Prostate Cancer Higher in University-Based vs Safety-Net Hospitals
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|